U.S. drug spending to spike at least 8% by mid-2020s with new Alzheimer's drug U.S. drug spending to spike at least 8% by mid-2020s with new Alzheimer's drug U.S. drug spending to spike at least 8% by mid-2020s with new Alzheimer's drug

U.S. drug spending to spike at least 8% by mid-2020s with new Alzheimer's drug

The research group Altarum estimates spending on the drug Aduhelm will comprise more than 1% of all national health spending by the mid-2020s, despite limited proof of efficacy.

from Section Page News - Modern Healthcare https://ift.tt/3qdeMW5